img

Global Paclitaxel Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Paclitaxel Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
Paclitaxel Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paclitaxel Injection market is projected to reach US$ 7130.2 million in 2034, increasing from US$ 3384 million in 2022, with the CAGR of 11.1% during the period of 2024 to 2034. Demand from Ovarian Cancer and Breast Cancer are the major drivers for the industry.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paclitaxel Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Segment by Type
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg

Segment by Application


Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Paclitaxel Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Paclitaxel Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Paclitaxel Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Paclitaxel Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Paclitaxel Injection introduction, etc. Paclitaxel Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Paclitaxel Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Paclitaxel Injection Market Overview
1.1 Paclitaxel Injection Product Overview
1.2 Paclitaxel Injection Market Segment by Type
1.2.1 5ml,30mg
1.2.2 10ml,60mg
1.2.3 16.7ml,100mg
1.2.4 25ml,150mg
1.2.5 50ml,300mg
1.3 Global Paclitaxel Injection Market Size by Type
1.3.1 Global Paclitaxel Injection Market Size Overview by Type (2018-2034)
1.3.2 Global Paclitaxel Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Paclitaxel Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Paclitaxel Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Paclitaxel Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Paclitaxel Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Paclitaxel Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Paclitaxel Injection Sales Breakdown by Type (2018-2024)
2 Global Paclitaxel Injection Market Competition by Company
2.1 Global Top Players by Paclitaxel Injection Sales (2018-2024)
2.2 Global Top Players by Paclitaxel Injection Revenue (2018-2024)
2.3 Global Top Players by Paclitaxel Injection Price (2018-2024)
2.4 Global Top Manufacturers Paclitaxel Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Paclitaxel Injection Market Competitive Situation and Trends
2.5.1 Paclitaxel Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Paclitaxel Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Paclitaxel Injection Market
2.8 Key Manufacturers Paclitaxel Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Paclitaxel Injection Status and Outlook by Region
3.1 Global Paclitaxel Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Paclitaxel Injection Historic Market Size by Region
3.2.1 Global Paclitaxel Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Paclitaxel Injection Sales in Value by Region (2018-2024)
3.2.3 Global Paclitaxel Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Paclitaxel Injection Forecasted Market Size by Region
3.3.1 Global Paclitaxel Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Paclitaxel Injection Sales in Value by Region (2024-2034)
3.3.3 Global Paclitaxel Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Paclitaxel Injection by Application
4.1 Paclitaxel Injection Market Segment by Application
4.1.1 Ovarian Cancer
4.1.2 Breast Cancer
4.1.3 Cervical Cancer
4.1.4 Pancreatic Cancer
4.1.5 Other
4.2 Global Paclitaxel Injection Market Size by Application
4.2.1 Global Paclitaxel Injection Market Size Overview by Application (2018-2034)
4.2.2 Global Paclitaxel Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Paclitaxel Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Paclitaxel Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Paclitaxel Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Paclitaxel Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Paclitaxel Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Paclitaxel Injection Sales Breakdown by Application (2018-2024)
5 North America Paclitaxel Injection by Country
5.1 North America Paclitaxel Injection Historic Market Size by Country
5.1.1 North America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Paclitaxel Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Paclitaxel Injection Sales in Value by Country (2018-2024)
5.2 North America Paclitaxel Injection Forecasted Market Size by Country
5.2.1 North America Paclitaxel Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Paclitaxel Injection Sales in Value by Country (2024-2034)
6 Europe Paclitaxel Injection by Country
6.1 Europe Paclitaxel Injection Historic Market Size by Country
6.1.1 Europe Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Paclitaxel Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Paclitaxel Injection Sales in Value by Country (2018-2024)
6.2 Europe Paclitaxel Injection Forecasted Market Size by Country
6.2.1 Europe Paclitaxel Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Paclitaxel Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Paclitaxel Injection by Region
7.1 Asia-Pacific Paclitaxel Injection Historic Market Size by Region
7.1.1 Asia-Pacific Paclitaxel Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Paclitaxel Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Paclitaxel Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Paclitaxel Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Paclitaxel Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Paclitaxel Injection Sales in Value by Region (2024-2034)
8 Latin America Paclitaxel Injection by Country
8.1 Latin America Paclitaxel Injection Historic Market Size by Country
8.1.1 Latin America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Paclitaxel Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Paclitaxel Injection Sales in Value by Country (2018-2024)
8.2 Latin America Paclitaxel Injection Forecasted Market Size by Country
8.2.1 Latin America Paclitaxel Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Paclitaxel Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Paclitaxel Injection by Country
9.1 Middle East and Africa Paclitaxel Injection Historic Market Size by Country
9.1.1 Middle East and Africa Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Paclitaxel Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Paclitaxel Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Paclitaxel Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Paclitaxel Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Paclitaxel Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bristol-Myers Squibb Paclitaxel Injection Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Celgene Corporation
10.2.1 Celgene Corporation Company Information
10.2.2 Celgene Corporation Introduction and Business Overview
10.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Celgene Corporation Paclitaxel Injection Products Offered
10.2.5 Celgene Corporation Recent Development
10.3 Hospira
10.3.1 Hospira Company Information
10.3.2 Hospira Introduction and Business Overview
10.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Hospira Paclitaxel Injection Products Offered
10.3.5 Hospira Recent Development
10.4 Biological E.
10.4.1 Biological E. Company Information
10.4.2 Biological E. Introduction and Business Overview
10.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biological E. Paclitaxel Injection Products Offered
10.4.5 Biological E. Recent Development
10.5 Taj Accura
10.5.1 Taj Accura Company Information
10.5.2 Taj Accura Introduction and Business Overview
10.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Taj Accura Paclitaxel Injection Products Offered
10.5.5 Taj Accura Recent Development
10.6 Khandelwal Laboratories
10.6.1 Khandelwal Laboratories Company Information
10.6.2 Khandelwal Laboratories Introduction and Business Overview
10.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Khandelwal Laboratories Paclitaxel Injection Products Offered
10.6.5 Khandelwal Laboratories Recent Development
10.7 Luye Pharma
10.7.1 Luye Pharma Company Information
10.7.2 Luye Pharma Introduction and Business Overview
10.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Luye Pharma Paclitaxel Injection Products Offered
10.7.5 Luye Pharma Recent Development
10.8 Beijing Youcare
10.8.1 Beijing Youcare Company Information
10.8.2 Beijing Youcare Introduction and Business Overview
10.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Beijing Youcare Paclitaxel Injection Products Offered
10.8.5 Beijing Youcare Recent Development
10.9 Beijing Union
10.9.1 Beijing Union Company Information
10.9.2 Beijing Union Introduction and Business Overview
10.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Beijing Union Paclitaxel Injection Products Offered
10.9.5 Beijing Union Recent Development
10.10 Haiyao
10.10.1 Haiyao Company Information
10.10.2 Haiyao Introduction and Business Overview
10.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Haiyao Paclitaxel Injection Products Offered
10.10.5 Haiyao Recent Development
10.11 Chuntch
10.11.1 Chuntch Company Information
10.11.2 Chuntch Introduction and Business Overview
10.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Chuntch Paclitaxel Injection Products Offered
10.11.5 Chuntch Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Paclitaxel Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Paclitaxel Injection Industrial Chain Analysis
11.4 Paclitaxel Injection Market Dynamics
11.4.1 Paclitaxel Injection Industry Trends
11.4.2 Paclitaxel Injection Market Drivers
11.4.3 Paclitaxel Injection Market Challenges
11.4.4 Paclitaxel Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Paclitaxel Injection Distributors
12.3 Paclitaxel Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 5ml,30mg
Table 2. Major Company of 10ml,60mg
Table 3. Major Company of 16.7ml,100mg
Table 4. Major Company of 25ml,150mg
Table 5. Major Company of 50ml,300mg
Table 6. Global Paclitaxel Injection Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Paclitaxel Injection Sales by Type (2018-2024) & (K Units)
Table 8. Global Paclitaxel Injection Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Paclitaxel Injection Sales by Type (2018-2024) & (US& Million)
Table 10. Global Paclitaxel Injection Market Share in Value by Type (2018-2024)
Table 11. Global Paclitaxel Injection Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Paclitaxel Injection Sales by Type (2024-2034) & (K Units)
Table 13. Global Paclitaxel Injection Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Paclitaxel Injection Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Paclitaxel Injection Sales Market Share in Value by Type (2024-2034)
Table 16. Global Paclitaxel Injection Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Paclitaxel Injection Sales by Type (2018-2024) & (K Units)
Table 18. North America Paclitaxel Injection Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Paclitaxel Injection Sales (K Units) by Type (2018-2024)
Table 20. Europe Paclitaxel Injection Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Paclitaxel Injection Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Paclitaxel Injection Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Paclitaxel Injection Sales (K Units) by Type (2018-2024)
Table 24. Latin America Paclitaxel Injection Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Paclitaxel Injection Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Paclitaxel Injection Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Paclitaxel Injection Sales by Company (2018-2024) & (K Units)
Table 28. Global Paclitaxel Injection Sales Share by Company (2018-2024)
Table 29. Global Paclitaxel Injection Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Paclitaxel Injection Revenue Share by Company (2018-2024)
Table 31. Global Market Paclitaxel Injection Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Paclitaxel Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Paclitaxel Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2022)
Table 35. Date of Key Manufacturers Enter into Paclitaxel Injection Market
Table 36. Key Manufacturers Paclitaxel Injection Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Paclitaxel Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Paclitaxel Injection Sales by Region (2018-2024) & (K Units)
Table 40. Global Paclitaxel Injection Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Paclitaxel Injection Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Paclitaxel Injection Sales Market Share in Value by Region (2018-2024)
Table 43. Global Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Paclitaxel Injection Sales by Region (2024-2034) & (K Units)
Table 45. Global Paclitaxel Injection Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Paclitaxel Injection Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Paclitaxel Injection Sales Market Share in Value by Region (2024-2034)
Table 48. Global Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Paclitaxel Injection Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Paclitaxel Injection Sales by Application (2018-2024) & (K Units)
Table 51. Global Paclitaxel Injection Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Paclitaxel Injection Sales Market Share in Value by Application (2018-2024)
Table 54. Global Paclitaxel Injection Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Paclitaxel Injection Sales by Application (2024-2034) & (K Units)
Table 56. Global Paclitaxel Injection Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Paclitaxel Injection Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Paclitaxel Injection Sales Market Share in Value by Application (2024-2034)
Table 59. Global Paclitaxel Injection Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Paclitaxel Injection Sales by Application (2018-2024) (K Units)
Table 61. North America Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Paclitaxel Injection Sales by Application (2018-2024) (K Units)
Table 63. Europe Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Paclitaxel Injection Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Paclitaxel Injection Sales by Application (2018-2024) (K Units)
Table 67. Latin America Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Paclitaxel Injection Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Paclitaxel Injection Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Paclitaxel Injection Sales by Country (2018-2024) & (K Units)
Table 71. North America Paclitaxel Injection Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Paclitaxel Injection Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Paclitaxel Injection Sales Market Share in Value by Country (2018-2024)
Table 74. North America Paclitaxel Injection Sales by Country (2024-2034) & (K Units)
Table 75. North America Paclitaxel Injection Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Paclitaxel Injection Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Paclitaxel Injection Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Paclitaxel Injection Sales by Country (2018-2024) & (K Units)
Table 79. Europe Paclitaxel Injection Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Paclitaxel Injection Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Paclitaxel Injection Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Paclitaxel Injection Sales by Country (2024-2034) & (K Units)
Table 83. Europe Paclitaxel Injection Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Paclitaxel Injection Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Paclitaxel Injection Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Paclitaxel Injection Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Paclitaxel Injection Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Paclitaxel Injection Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Paclitaxel Injection Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Paclitaxel Injection Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Paclitaxel Injection Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Paclitaxel Injection Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Paclitaxel Injection Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Paclitaxel Injection Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Paclitaxel Injection Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Paclitaxel Injection Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Paclitaxel Injection Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Paclitaxel Injection Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Paclitaxel Injection Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Paclitaxel Injection Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Paclitaxel Injection Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Paclitaxel Injection Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Paclitaxel Injection Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Country (2024-2034)
Table 110. Bristol-Myers Squibb Company Information
Table 111. Bristol-Myers Squibb Introduction and Business Overview
Table 112. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Bristol-Myers Squibb Paclitaxel Injection Product
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Celgene Corporation Company Information
Table 116. Celgene Corporation Introduction and Business Overview
Table 117. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Celgene Corporation Paclitaxel Injection Product
Table 119. Celgene Corporation Recent Development
Table 120. Hospira Company Information
Table 121. Hospira Introduction and Business Overview
Table 122. Hospira Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Hospira Paclitaxel Injection Product
Table 124. Hospira Recent Development
Table 125. Biological E. Company Information
Table 126. Biological E. Introduction and Business Overview
Table 127. Biological E. Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Biological E. Paclitaxel Injection Product
Table 129. Biological E. Recent Development
Table 130. Taj Accura Company Information
Table 131. Taj Accura Introduction and Business Overview
Table 132. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Taj Accura Paclitaxel Injection Product
Table 134. Taj Accura Recent Development
Table 135. Khandelwal Laboratories Company Information
Table 136. Khandelwal Laboratories Introduction and Business Overview
Table 137. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Khandelwal Laboratories Paclitaxel Injection Product
Table 139. Khandelwal Laboratories Recent Development
Table 140. Luye Pharma Company Information
Table 141. Luye Pharma Introduction and Business Overview
Table 142. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Luye Pharma Paclitaxel Injection Product
Table 144. Luye Pharma Recent Development
Table 145. Beijing Youcare Company Information
Table 146. Beijing Youcare Introduction and Business Overview
Table 147. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Beijing Youcare Paclitaxel Injection Product
Table 149. Beijing Youcare Recent Development
Table 150. Beijing Union Company Information
Table 151. Beijing Union Introduction and Business Overview
Table 152. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Beijing Union Paclitaxel Injection Product
Table 154. Beijing Union Recent Development
Table 155. Haiyao Company Information
Table 156. Haiyao Introduction and Business Overview
Table 157. Haiyao Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. Haiyao Paclitaxel Injection Product
Table 159. Haiyao Recent Development
Table 160. Chuntch Company Information
Table 161. Chuntch Introduction and Business Overview
Table 162. Chuntch Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Chuntch Paclitaxel Injection Product
Table 164. Chuntch Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Paclitaxel Injection Market Trends
Table 168. Paclitaxel Injection Market Drivers
Table 169. Paclitaxel Injection Market Challenges
Table 170. Paclitaxel Injection Market Restraints
Table 171. Paclitaxel Injection Distributors List
Table 172. Paclitaxel Injection Downstream Customers
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Injection Product Picture
Figure 2. Global Paclitaxel Injection Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Paclitaxel Injection Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Paclitaxel Injection Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of 5ml,30mg
Figure 6. Global 5ml,30mg Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of 10ml,60mg
Figure 8. Global 10ml,60mg Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of 16.7ml,100mg
Figure 10. Global 16.7ml,100mg Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of 25ml,150mg
Figure 12. Global 25ml,150mg Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of 50ml,300mg
Figure 14. Global 50ml,300mg Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Paclitaxel Injection Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Paclitaxel Injection Sales Market Share by Type in 2022 & 2034
Figure 17. North America Paclitaxel Injection Sales Market Share in Volume by Type in 2022
Figure 18. North America Paclitaxel Injection Sales Market Share in Value by Type in 2022
Figure 19. Europe Paclitaxel Injection Sales Market Share in Volume by Type in 2022
Figure 20. Europe Paclitaxel Injection Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Type in 2022
Figure 23. Latin America Paclitaxel Injection Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Paclitaxel Injection Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Paclitaxel Injection Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Injection Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Injection Revenue in 2022
Figure 29. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Ovarian Cancer
Figure 31. Global Ovarian Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Breast Cancer
Figure 33. Global Breast Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Cervical Cancer
Figure 35. Global Cervical Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Pancreatic Cancer
Figure 37. Global Pancreatic Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Other
Figure 39. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Global Paclitaxel Injection Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Paclitaxel Injection Sales Market Share by Application in 2022 & 2034
Figure 42. North America Paclitaxel Injection Sales Market Share in Volume by Application in 2022
Figure 43. North America Paclitaxel Injection Sales Market Share in Value by Application in 2022
Figure 44. Europe Paclitaxel Injection Sales Market Share in Volume by Application in 2022
Figure 45. Europe Paclitaxel Injection Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Application in 2022
Figure 48. Latin America Paclitaxel Injection Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Paclitaxel Injection Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Paclitaxel Injection Manufacturing Cost Structure
Figure 53. Paclitaxel Injection Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries